Jennifer Tousignant
Chief Legal Officer · 4 filings · Latest: Aug 19, 2026
Viridian Therapeutics, Inc.\DE
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VRDN | Jennifer Tousignant | Chief Legal Officer | Aug 19, 2026 | Option Exercise | $14.41 | 10,000 | $144.1K | 10,000 | |
VRDN | Jennifer Tousignant | Chief Legal Officer | Aug 19, 2026 | Sale | $24.50 | 14,212 | $348.2K | 0 | |
VRDN | Tousignant Jennifer | — | Aug 19, 2026 | Proposed Sale | $24.50 | 14,212 | $348.2K | — | |
VRDN | Jennifer Tousignant | Chief Legal Officer | Mar 3, 2026 | Option Exercise | — | 5,169 | — | 5,169 | |
VRDN | Tousignant Jennifer | — | Mar 4, 2026 | Proposed Sale | $30.19 | 1,675 | $50.6K | — | |
VRDN | Tousignant Jennifer | — | Dec 31, 2025 | Proposed Sale | $31.16 | 2,272 | $70.8K | — |